Form 8-K - Current report:
SEC Accession No. 0001356576-22-000027
Filing Date
2022-04-13
Accepted
2022-04-13 16:18:01
Documents
14
Period of Report
2022-04-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20220413.htm   iXBRL 8-K 39618
2 EX-99.1 ex99104-13x2022.htm EX-99.1 153754
6 supernuslogoa.jpg GRAPHIC 19991
  Complete submission text file 0001356576-22-000027.txt   370919

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20220413.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20220413_lab.xml EX-101.LAB 24136
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20220413_pre.xml EX-101.PRE 12520
8 EXTRACTED XBRL INSTANCE DOCUMENT supn-20220413_htm.xml XML 10852
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 22824901
SIC: 2834 Pharmaceutical Preparations